Carboxy-terminal collagen crosslinks (CTX)
Carboxy-terminal collagen crosslinks (CTX) reflects the resorption of mature collagen by osteoclasts. Used to assess patient response to antiresorptive therapy / compliance. Baseline level required. Levels are increased in any condition with increased osteoclast activity such as immobilisation, Paget's disease, osteoporosis, metastatic cancer, primary hyperparathyroidism.
|Tube||04 (EP) - EDTA Plasma|
|Additional Information||This test is reserved for use by the bone clinic only.|
|Turn Around||Turnaround time stated by Norfolk and Norwich: 2 weeks.|
|Send to||Blood Sciences LGI
(Test referred to: Norfolk and Norwich University Hospital.)
|Contact||For further details please contact Leeds Pathology customer services: email@example.com.|
|Collection Con||Minimum Volume: 0.5ml EDTA serum.
A single EDTA tube may be sent for both CTX and P1NP. Instructions to lab: Centrifuge sample, separate and freeze plasma.
|Ref. Range Notes||Male 0.1 - 0.5 ug/L, Female 0.1 - 0.5 ug/L|
|Telepath||LGI superset LCTX. SJUH superset JCTX.|